Integrated iCRO Advantage Veranex positions as the world’s first global Innovation Contract Research Organization (iCRO) offering integrated product development and contract research across medical devices and in vitro diagnostics, which can shorten timelines and reduce budget variance for potential clients seeking end-to-end development partners.

End-to-End Capacity With over 800 specialists and more than 15 innovation and research centers across North America, Europe, and Asia-Pacific, Veranex offers broad geographic coverage and multi-discipline expertise that can support global device programs and rapid scaleups.

Strategic M&A Momentum Recent acquisitions including HORUS Scientific and T3 Labs, plus expansion through the Innovation CRO model, signal a growth strategy to broaden capabilities in pathology, preclinical services, and integrated regulatory and market access, creating cross-sell opportunities.

Clinical and Regulatory Edge Veranex combines design engineering, preclinical, clinical, regulatory, quality, and market access services under one roof, enabling smoother handoffs and faster time-to-market for medical devices and diagnostics—a compelling value proposition for risk-averse sponsors seeking efficiency.

Targeted Market Expansion Active engagements with startups to global strategics in cardiovascular, neurovascular, ophthalmology, and diagnostic markets, plus notable client wins like Atraverse Medical, indicate ongoing opportunities to expand within high-growth device segments and navigate capital-tight R&D environments.